The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs
Théo Accogli, Christophe Hibos, L. Mayea Milian, Mannon Geindreau, Corentin Richard, Étienne Humblin, Romain Mary, Sandy Chevrier, Élise Jacquin, Antoine Bernard, Fanny Chalmin, Catherine Paul, Bernhard Ryffel, Lionel Apétoh, Romain Boidot, Mélanie Bruchard, François Ghiringhelli, Frédérique Végran
Abstract
Th17 cells can perform either regulatory or inflammatory functions depending on the cytokine microenvironment. These plastic cells can transdifferentiate into Tregs during inflammation resolution, in allogenic heart transplantation models, or in cancer through mechanisms that remain poorly understood. Here, we demonstrated that NLRP3 expression in Th17 cells is essential for maintaining their immunosuppressive functions through an inflammasome-independent mechanism. In the absence of NLRP3, Th17 cells produce more inflammatory cytokines (IFNγ, Granzyme B, TNFα) and exhibit reduced immunosuppressive activity toward CD8+ cells. Moreover, the capacity of NLRP3-deficient Th17 cells to transdifferentiate into Treg-like cells is lost. Mechanistically, NLRP3 in Th17 cells interacts with the TGF-β receptor, enabling SMAD3 phosphorylation and thereby facilitating the acquisition of immunosuppressive functions. Consequently, the absence of NLRP3 expression in Th17 cells from tumor-bearing mice enhances CD8 + T-cell effectiveness, ultimately inhibiting tumor growth.